Based on UNM technology, Intellicyt created an intelligent cytometry platform that specializes in delivering tools and solutions to answer fundamental and complex biological questions through both suspension-cell-based and bead-based analyses. Terry, a distinguished member of NMBio’s board of directors, will provide his insights on the hurdles that New Mexico’s most successful bioscience start-up company had to overcome on its path to success and becoming the largest acquisition in New Mexico history.